300584 Stock Overview
Engages in the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Nanjing Hicin Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.27 |
| 52 Week High | CN¥28.07 |
| 52 Week Low | CN¥12.68 |
| Beta | 0.20 |
| 11 Month Change | -1.68% |
| 3 Month Change | 11.07% |
| 1 Year Change | -18.78% |
| 33 Year Change | 31.39% |
| 5 Year Change | -17.27% |
| Change since IPO | 108.78% |
Recent News & Updates
Recent updates
There's Reason For Concern Over Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) Massive 28% Price Jump
Aug 15
We Think Nanjing Hicin Pharmaceutical's (SZSE:300584) Profit Is Only A Baseline For What They Can Achieve
May 01Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) 29% Price Boost Is Out Of Tune With Revenues
Mar 08Shareholder Returns
| 300584 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.2% | -1.5% | -2.1% |
| 1Y | -18.8% | -9.4% | 2.8% |
Return vs Industry: 300584 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.
Return vs Market: 300584 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 300584 volatility | |
|---|---|
| 300584 Average Weekly Movement | 11.4% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300584's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300584's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 553 | Yuping Cao | www.hicin.cn/page1/index1 |
Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals in China. It offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. The company also provides technical transferring services.
Nanjing Hicin Pharmaceutical Co., Ltd. Fundamentals Summary
| 300584 fundamental statistics | |
|---|---|
| Market cap | CN¥2.67b |
| Earnings (TTM) | CN¥42.01m |
| Revenue (TTM) | CN¥500.38m |
63.6x
P/E Ratio5.3x
P/S RatioIs 300584 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300584 income statement (TTM) | |
|---|---|
| Revenue | CN¥500.38m |
| Cost of Revenue | CN¥93.05m |
| Gross Profit | CN¥407.33m |
| Other Expenses | CN¥365.32m |
| Earnings | CN¥42.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 81.40% |
| Net Profit Margin | 8.40% |
| Debt/Equity Ratio | 28.8% |
How did 300584 perform over the long term?
See historical performance and comparison